Business Description
Cyclezyme AB
ISIN : SE0020975852
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.61 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 544.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.1 | |||||
9-Day RSI | 44.71 | |||||
14-Day RSI | 43.56 | |||||
6-1 Month Momentum % | 133.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.81 | |||||
Quick Ratio | 7.81 | |||||
Cash Ratio | 7.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -45 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -35.53 | |||||
ROA % | -29.74 | |||||
ROIC % | -121.14 | |||||
ROC (Joel Greenblatt) % | -567.3 | |||||
ROCE % | -33.14 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 2.81 | |||||
EV-to-EBIT | -8.33 | |||||
EV-to-EBITDA | -8.33 | |||||
EV-to-FCF | -3.74 | |||||
Price-to-Net-Current-Asset-Value | 2.95 | |||||
Price-to-Net-Cash | 3.3 | |||||
Earnings Yield (Greenblatt) % | -12 | |||||
FCF Yield % | -22.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cyclezyme AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -2.65 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 43.56 | ||
14-Day ATR (kr) | 1.276523 | ||
20-Day SMA (kr) | 7.45 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 3 - 18.9 | ||
Shares Outstanding (Mil) | 2.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cyclezyme AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cyclezyme AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Cyclezyme AB Frequently Asked Questions
What is Cyclezyme AB(XSAT:CYCLE)'s stock price today?
When is next earnings date of Cyclezyme AB(XSAT:CYCLE)?
Does Cyclezyme AB(XSAT:CYCLE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |